Patrick Finn, Ph.D.

Patrick Finn, Ph.D.

President and Chief Operating OfficeratTwist Bioscience· In proxies 2021–2025

Pay in FY2025+108% from the year before · Twist Bioscience stock -37.7% the same year

Patrick Finn, Ph.D. was paid $8.0M in FY2025 (Sep), up 108%. Twist Bioscience stock fell 37.7% that year.

Pay$100 in the stock at the end of FY20 → $37
Pay is from the Summary Compensation Table of each Twist Bioscience proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Twist BiosciencePublic company · 5 yr
    • President and Chief Operating Officer2021 – Present · 5 yrStock in role +168%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?